Practice Management

Top Story

Government shutdown threatens biosimilar approvals, patent litigation

Government shutdown threatens biosimilar approvals, patent litigation
January 18, 2019
Feature

Direct-to-consumer genetic testing not ready for prime time in rheumatology

January 18, 2019
Splashy headlines in the mainstream media that proclaim advances in medicine are often not what they seem. That may be the case with a recent series of FDA approvals…
In the Journals

Medicare Part B to D shift may decrease total spending, increase out-of-pocket costs

January 17, 2019
Although a proposal by the HHS to shift certain prescription drugs from Medicare Part B to Part D may reduce total drug spending by 6.9% to 18.3%, it could also increase…
In the Journals

Medicare Part D could save $14.4B using VA drug prices

January 14, 2019
If Medicare Part D paid prices for prescription medications similar to what the Department of Veterans Affairs pays, there could be an estimated annual savings of 38% to…
More Headlines »
CME

Rheumatic Complications of Cancer Immunotherapy: A New and Emerging Field in Rheumatology

This activity is supported by an educational grant from Bristol-Myers Squibb.

The introduction of immune checkpoint inhibitors has had a great impact on the field of oncology. However, these new…
More »
Video
Meeting News

VIDEO: Digital marketing offers a ‘clear’ return on investment for physicians

August 15, 2018
More »
Resource Centers